Pfizer helps poorest countries

20 March 2006

Global pharmaceutical leader Pfizer has released data about its development aid, which reinforces the message of the Geneva, Switzerland-headquartered International Federation of Pharmaceutical Manufacturers and Asso-ciations (Marketletter March 13), that drugmakers have contributed over $4.38 billion in five years.

Pfizer chairman Hank McKinnell, in a statement issued in New York, USA, said: "at almost $4.4 billion contributed so far this decade, our industry is clearly part of the solu-tion to addressing the urgent medical needs of millions of people in developing countries." He added that Pfizer supports IFPMA president Daniel Vasella's call for drug companies to publish regular figures of their philanthropic contributions and programs, saying: "Pfizer has consis-tently done this for many years."

Pfizer: over 20% of global donation estimate

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight